ArticleOncoimmunology2020

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation.

Ieva Saulite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.